Partner Hospital · Shanghai

Zhongshan Hospital Shanghai
China’s #1 Liver Cancer Surgery & Cardiovascular Benchmark

Zhongshan Hospital Fudan University has performed more hepatocellular carcinoma (HCC) resections than any other hospital in China — making it the undisputed national authority for liver cancer surgery. Founded in 1937 and affiliated with Fudan University's medical school, the hospital is equally renowned for cardiovascular medicine, performing over 10,000 cardiac procedures annually. Its endoscopy centre is among the highest-volume in the world. For international patients with liver disease, liver cancer, cardiac conditions, or complex GI pathology, Zhongshan offers expertise that is genuinely difficult to find anywhere else.

#1
Liver cancer surgery China
10,000+
Cardiac procedures/year
World #1
Endoscopy volume
1937
Year established
Zhongshan Hospital Fudan University Shanghai — China's #1 liver cancer surgery and cardiovascular centre
About the Hospital

China’s Liver Cancer Surgery Leader & Cardiovascular Benchmark

Zhongshan Hospital (中山医院) was established in 1937 and is affiliated with Fudan University School of Medicine. It consistently ranks in China's top 5 hospitals and holds the national #1 position in liver surgery — specifically hepatocellular carcinoma (HCC) resection, where the hospital has performed more liver cancer operations than any other institution in China. This extraordinary volume of liver cancer surgery translates into surgical expertise that is globally competitive.

The hospital's cardiovascular medicine programme is equally exceptional. With over 10,000 cardiac procedures annually — spanning PCI, coronary angiography, structural heart intervention (TAVI, MitraClip), electrophysiology, and cardiac surgery — Zhongshan's cardiology and cardiac surgery departments are national reference centres for complex cardiovascular disease. The hospital is particularly known for managing patients where liver disease and cardiovascular disease coexist, a common clinical scenario in China's aging population.

Zhongshan's endoscopy centre processes one of the highest annual procedure volumes in the world, making it a reference centre for advanced endoscopic techniques: ESD (endoscopic submucosal dissection) for early gastric and colorectal cancer, ERCP for biliary disease, and EUS (endoscopic ultrasound) for pancreatic and GI diagnosis.

"If your liver has a problem — cancer, cirrhosis, or something requiring surgery — there is no hospital in China that has operated on more livers than Zhongshan."
Founded 1937 Xuhui, Shanghai Fudan University Public 3A
Zhongshan Hospital Shanghai campus — Fudan University liver cancer and cardiovascular national centre

Zhongshan Hospital Fudan University, Xuhui District, Shanghai.

#1
Liver cancer surgery China
10,000+
Cardiac procedures/year
1937
Year established
World #1
Endoscopy centre volume
Why Patients Choose Zhongshan

Three reasons international patients choose Zhongshan Hospital Shanghai

L
Liver Cancer Surgery Leader

No hospital in China has performed more hepatocellular carcinoma resections than Zhongshan. The surgical teams are highly experienced in laparoscopic and robotic-assisted liver resection, complex multi-segment hepatectomy, and repeat liver surgery for recurrent HCC. They are also experienced in combination approaches — surgery plus TACE, radiofrequency ablation, or targeted therapy — managed by a dedicated liver tumour multidisciplinary board.

Cardiovascular Excellence

Zhongshan performs over 10,000 cardiac procedures annually, including coronary intervention (PCI), TAVI and MitraClip structural heart procedures, electrophysiology and ablation, and cardiac surgery. The cardiology department is the national benchmark for several cardiovascular conditions and holds particular expertise in managing complex cardiovascular disease in patients with comorbid liver disease — a combination where Zhongshan's dual strength is uniquely valuable.

GI
Complex GI & Endoscopy

Zhongshan's endoscopy centre is one of the highest-volume in the world, processing tens of thousands of procedures annually. Advanced endoscopic resection (ESD) for early gastric and colorectal cancer, ERCP for bile duct stones and biliary strictures, and EUS-guided biopsies are all routine. For patients who need a technically demanding endoscopic procedure, very few hospitals in the world match Zhongshan's volume-driven expertise.

Clinical Departments

Specialties Available to International Patients

Zhongshan Hospital covers more than 40 clinical departments with particular national recognition in the following areas.

Liver Cancer & Hepatobiliary
China's #1 for HCC surgery. Laparoscopic and robotic liver resection, complex hepatectomy, repeat liver surgery for recurrent HCC. TACE, radiofrequency ablation, microwave ablation. Targeted therapy (sorafenib, lenvatinib, regorafenib) and immunotherapy (PD-1 inhibitors) coordinated by multidisciplinary liver tumour board.
HCC Surgery #1 China Laparoscopic Hepatectomy TACE Targeted Therapy
Cardiology & Cardiac Surgery
Over 10,000 cardiac procedures annually. Coronary angiography, PCI, TAVI, MitraClip, left atrial appendage occlusion, electrophysiology and ablation. Cardiac surgery: CABG, valve surgery, aortic surgery. National benchmark for structural heart intervention.
TAVI / MitraClip PCI Cardiac Surgery Electrophysiology
Endoscopy & GI
World-leading endoscopy volume. ESD for early gastric and colorectal cancer. ERCP for biliary stones and strictures. EUS for pancreatic tumours and subepithelial lesions. Colonoscopy with polypectomy. Advanced endoscopy for complex cases referred nationally.
ESD ERCP EUS
Pulmonology
Nationally ranked pulmonology department managing COPD, interstitial lung disease, lung cancer (diagnosis and staging), pulmonary hypertension, and complex respiratory failure. Bronchoscopy, EBUS-guided lung biopsy, and interventional bronchoscopy available.
COPD Interstitial Lung Disease EBUS Biopsy
Organ Transplantation
Liver transplantation for end-stage liver disease, hepatocellular carcinoma within Milan criteria, and acute liver failure. Kidney transplantation. Post-transplant immunosuppression management. One of China's most experienced liver transplant centres with strong long-term outcome data.
Liver Transplantation Kidney Transplantation Post-Transplant Care
Step-by-Step

How to Access Treatment at Zhongshan Hospital

China Care manages the full referral and coordination process, from case submission to discharge documentation.

1
Submit Your Case to China Care

Share your medical records and imaging. For liver cancer cases, include liver MRI or CT with contrast, AFP tumour marker levels, Child-Pugh liver function score, and any prior treatment history (TACE, ablation, systemic therapy). For cardiac cases, include echocardiogram, coronary angiogram (if available), and cardiology assessment. China Care prepares a bilingual case summary within 1–2 working days.

records review · 1–2 days
2
Zhongshan MDT Reviews Your Case

The relevant department reviews your case. Liver cancer cases are typically reviewed by the liver surgery multidisciplinary board, which includes hepatobiliary surgeons, interventional radiologists, and medical oncologists. Cardiac cases are assessed by the cardiology and cardiac surgery team. Most cases receive an initial response within 24–48 hours.

MDT review · 24–48 hours
3
Consultation & Visa Support

China Care arranges your consultation at Zhongshan Hospital. For patients requiring a medical visa, Zhongshan's international patient office issues a formal invitation letter. China Care prepares the complete documentation package for your embassy application. Shanghai's Pudong and Hongqiao airports have excellent international connectivity.

S2 visa invitation letter
4
Surgery & Treatment Coordination

China Care coordinates your hospital admission and pre-operative logistics. For liver surgery, pre-operative workup typically takes 2–3 days before the operation. The surgical team discusses the planned approach, risks, and recovery expectations before proceeding. China Care remains available throughout for communication support and any logistical assistance.

China Care on-ground support
5
Discharge & Follow-Up Planning

Full discharge documentation is provided including surgical report, pathology results, post-operative imaging, and follow-up recommendations. For liver cancer patients, a surveillance imaging schedule (CT/MRI every 3–4 months) is established. China Care ensures documentation is prepared in a format compatible with your home physician and arranges any return visit scheduling.

bilingual discharge · surveillance plan
Access Zhongshan Hospital via China Care
China Care coordinates all referrals to Zhongshan Hospital's international patient team
Get Your Case Reviewed at Zhongshan
China's #1 liver cancer surgery 10,000+ cardiac procedures/year MDT liver tumour board Medical visa support Bilingual discharge documentation China Care on-ground support
Common Questions

What patients ask about Zhongshan Hospital Shanghai.

What liver cancer surgery options are available at Zhongshan?
Zhongshan's liver surgery team performs the full spectrum of hepatocellular carcinoma (HCC) treatments: hepatectomy (partial liver resection) for resectable HCC, repeat hepatectomy for recurrent HCC after prior surgery, laparoscopic and robotic-assisted liver resection for suitable cases, and liver transplantation for HCC within transplant criteria. For unresectable HCC, the multidisciplinary board manages TACE (transarterial chemoembolisation), radiofrequency or microwave ablation, targeted therapy, and immunotherapy — often in combination. China Care submits your imaging for a pre-travel resectability assessment so you know your surgical options before travelling.
What cardiac interventions are available and what are the wait times?
Zhongshan performs the full range of cardiac procedures: PCI for coronary artery disease, TAVI and MitraClip for structural heart disease, electrophysiology studies and ablation for arrhythmias, CABG and valve surgery for surgical cases, and left atrial appendage occlusion for stroke prevention in atrial fibrillation. Wait times for elective procedures vary — urgent cases are prioritised. China Care confirms current scheduling availability at the time of your referral, typically within 2–4 weeks for elective procedures.
Is Zhongshan also appropriate for patients needing endoscopy or GI procedures?
Yes — Zhongshan's endoscopy centre is one of the world's highest-volume, and its advanced endoscopic capabilities are exceptional. ESD (endoscopic submucosal dissection) for early gastric and colorectal cancer avoids open surgery for lesions without lymph node involvement. ERCP removes bile duct stones and treats biliary strictures endoscopically. EUS provides guided biopsies of pancreatic tumours and subepithelial lesions that cannot be reached by other means. These procedures require high technical expertise, and Zhongshan's volume-driven experience produces reliable outcomes for complex cases.
What do liver cancer treatment costs look like at Zhongshan?
Liver resection surgery at Zhongshan typically costs USD 15,000–30,000 all-inclusive (surgery, anaesthesia, inpatient stay of 7–10 days), compared to USD 60,000–150,000 in the United States. TACE costs approximately USD 3,000–6,000 per session. Liver transplantation costs USD 40,000–80,000 all-inclusive versus USD 300,000–600,000 in the US. Treatment costs are quoted directly by the hospital. China Care provides a full cost breakdown before you commit to travel.
How does Zhongshan support international patients during their stay?
Zhongshan Hospital has an international patient coordination team that manages admission, key clinical communications, and discharge documentation for overseas patients. China Care provides supplementary on-ground support throughout your stay. Shanghai is one of the most internationally navigable cities in China, with a wide range of accommodation options near the hospital in Xuhui District. The hospital is easily accessible from both Pudong and Hongqiao airports. Family members accompanying patients have excellent options for accommodation and daily life in the surrounding area.
Should I choose Zhongshan or FUSCC for liver cancer treatment in Shanghai?
For liver cancer (HCC), Zhongshan is the clear first choice due to its #1 national ranking in liver surgery by sheer volume and outcome data. FUSCC is the better choice for breast cancer, lung cancer, or GI cancers where its dedicated oncology environment and broader trial access are more relevant. For a patient with liver cancer who also has significant cardiovascular comorbidity, Zhongshan's dual strength in hepatobiliary surgery and cardiology is a genuine advantage. China Care helps you assess which hospital is the best fit for your complete clinical picture.
Get Started

Ready to get your case reviewed at Zhongshan Hospital?

Submit your records through China Care and we will arrange your case review with Zhongshan Hospital's specialist team, typically within 1–2 working days.

China Care coordinates your case with Zhongshan Hospital's international patient team. Treatment costs are quoted directly by the hospital. We never add to or mark up the hospital's quoted treatment cost.